A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation

Overview of attention for article published in Cardiovascular Diabetology, February 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 3 X users

f1000: 1 research highlight platform

Citations

dimensions_citation: 122 Dimensions

Readers on

mendeley: 164 Mendeley

Summary X Research highlights Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,200 followers.

@kamleshkhunti @parthaskar @ABCDiab @AbdTahrani @drpatrickholmes https://t.co/qz7CZSaoHu

22 Mar 2019

Reply Repost Favourite

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation. - PubMed - NCBI https://t.co/YkHtTxKDEH

26 Nov 2017

Reply Repost Favourite

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular… https://t.co/awbr6qyQLY

05 Oct 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.